Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Myriad Genetics (MYGN) Pension (2016)

Historic Pension for Myriad Genetics (MYGN) over the last 2 years, with Q3 2016 value amounting to $6.1 million.

Myriad Genetics' Pension rose 2448.98% to $6.1 million in Q3 2016 from the same period last year, while for Sep 2016 it was $6.1 million, marking a year-over-year increase of 2448.98%. This contributed to the annual value of $5.9 million for FY2016, which is 2040.82% up from last year.
Per Myriad Genetics' latest filing, its Pension stood at $6.1 million for Q3 2016, which was up 2448.98% from $5.9 million recorded in Q2 2016.
Myriad Genetics' Pension's 5-year high stood at $6.1 million during Q3 2016, with a 5-year trough of $4.8 million in Q4 2015.